ArticleChemical research in toxicology2026
Agricultural Copper Pesticide Exposure and Metabolic Profiles among Parkinson's Disease Cases and Community Controls in California.
Article in Chemical research in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Copper-based pesticide exposures have been linked to increased Parkinson's disease (PD) risk through oxidative stress, mitochondrial dysfunction, and neuroinflammation, yet their metabolic effects in PD remain poorly understood. Using high-resolution metabolomics (HRM) data from 642 PD patients and 277 controls from the Parkinson's Environment and Gene (PEG) study, we evaluated alterations associated with chronic copper pesticide exposure. Composite and individual copper pesticide estimates were derived within a 500-m buffer around residential and workplace addresses over 5 years prior to the blood draw. Metabolome-wide association studies (MWAS) using partial least-squares (PLS) and empirical Bayes linear models were conducted to identify copper-associated metabolites, and pathway enrichment was performed using the Mummichog algorithm with 100 permutations to identify enriched metabolic pathways. In the primary analysis of the composite copper metric, we detected 215 copper-associated metabolite features, 88 of which were annotated, while none of them survived the FDR < 0.05 threshold. In individual-pesticide analyses, only copper sulfate (pentahydrate) yielded significant results: 57 metabolite features passed the FDR < 0.05 threshold (51 in PD patients, 4 in controls, and 2 in the full sample). The strongest metabolite association was with a phosphatidylcholine, PC(22:2(13Z,16Z)/16:1(9Z)) (β = 0.07,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.